Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center, Seattle, WA

Recorded on February 4, 2020

In this special episode, Dr. Miller sits down with Dr. Frederick Appelbaum, Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center, Professor, Division of Medical Oncology, at the University Of Washington School Of Medicine in Seattle, WA to discuss the history, current treatment and future of hematopoietic stem cell transplantation (HSCT) to treat blood cancers. Dr. Appelbaum shares insights on the importance of identifying a potential transplant candidate early on, roadblocks to receiving a transplant, improvements in survival rates, patient communication, and learnings from HSCT that offer the possibility of using transplant for other diseases.

Frederick R. Appelbaum, MD

Executive Director and Deputy Director

Fred Hutchinson Cancer Research Center Seattle, WA